VBI Vaccines Announces First Quarter 2019 Financial Results and Provides Corporate Update All four lead pipeline programs progressing towards expected clinical milestones in 2019Gearing up for top-line data from the pivotal Phase 3 study of Sci-B-Vac®, VBI’s trivalent hepatitis B vaccine,...